Synta Pharmaceuticals Merges With Privately Held Madrigal

Madrigal will own 64% of the combined company; the deal should finalize in Q3.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.